Table 1 Literature review of myeloid sarcoma involving the gynecologic tract

1 [6]

B. Pathak et al., Canada, 2005

25

Cervix—76% (n = 19)

Uterine corpus—8% (n = 2)

External genital organs—4% (n = 1)

 ≥ 2 gynecologic sites—4% (n = 1)

Not stated—8% (n = 2)

48% (n = 12)

CT

28 (7)

7.7

RT

8 (2)

5

SI

8 (2)

3

CT + RT

24 (6)

13.75

CT + SI

8 (2)

20.5

RT + SI

4 (1)

1.75

Without treatment

16 (4)

 < 1

2 [40]

R.M. Kahn et al., USA, 2019

1

 ≥ 2 gynecologic sites (uterine corpus, fallopian tubes, left ovary)

Yes

CT + SI

3

3 [12]

G.Modi et al., India, 2004

1

External genital organs (vagina)

No

Hypomethylating therapy with decitabine

> 4

4 [41]

J.-A. Hernández et al., Spain, 2002

2

Cervix, left mesosalpinx, ovaries

100% (n = 2)

CT + SI + autoBMT

10

External genital organs (vagina)

CT + autoBMT

10

5 [42]

M. Ucar, M. Guryildirim, Turkey, 2014

1

Breast, cervix, uterus

Yes

CT

> 2

6 [43]

M.G. Garcia et al., USA, Spain, 2006

11

Cervix—27.3% (n = 3)

Ovary—18.2% (n = 2)

Uterine corpus—9% (n = 1)

External genital organs—9% (n = 1)

 ≥ 2 gynecologic sites—36.5% (n = 4)

36.5% (n = 4)

CT

64 (7)

40

RT

9 (1)

5

CT + alloBMT

9 (1)

> 6

SI

73 (8)

-

9

Cervix—11% (n = 1)

Ovary—89% (n = 8)

22% (n = 2)

CT

33 (3)

15

CT + alloBMT

11 (1)

10

7 [44]

S.C.H. Kim et al., France, 2010

1

Cervix

No

CT + RT

> 72

8 [45]

H. Gill et al., China, 2012

1

Cervix, left pelvic cavity

No

CT

16

9 [7]

W. Gui et al., China, 2019

2

Cervix, external genital organs (vagina), intrapelvic lymph nodes

No

SI + CT

21

Cervix, uterus, intrapelvic lymph nodes

Yes

CT

26

10 [46]

A.S. Weingertner et al., France, 2009

1

Cervix, intrapelvic lymph nodes

Yes

CT

> 3

11 [47]

Y. Yu et al., China, 2015

1

External genital organs (vulva, vagina), cervix

No

CT

4

12 [48]

H. Bao et al., China, 2019

1

External genital organs

Yes

SI + CT + alloBMT

> 6